Search research articles
Contact Us
Filters
Showing results (31-40 of 76) with videos related to
Page
of 8
Sort By:
European Journal of Neurology
|
July 27, 2004
Therapeutic outcome in neuropathic pain: relationship to evidence of nervous system lesion
P V Rasmussen, S H Sindrup, T S Jensen, et al.
Psychopharmacology Series
|
January 1, 1993
Role of genetic polymorphism in psychopharmacology--an update
K Brøsen, S H Sindrup, E Skjelbo, et al.
Acta Anaesthesiologica Scandinavica
|
September 2, 2009
Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia
S T Zwisler, T P Enggaard, S Mikkelsen, et al.
European Journal of Neurology
|
February 25, 2009
Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial
T Harbo, H Andersen, A Hess, et al.
European Journal of Neurology
|
April 26, 2019
Randomized trial of facilitated subcutaneous immunoglobulin in multifocal motor neuropathy
A Al-Zuhairy, J Jakobsen, H Andersen, et al.
Clinical Pharmacology and Therapeutics
|
May 21, 2005
Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective O-demethylation and reduces the hypoalgesic effect of tramadol
S Laugesen, T P Enggaard, R S Pedersen, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1990
Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms
S H Sindrup, L F Gram, T Skjold, et al.
European Journal of Clinical Pharmacology
|
April 25, 2001
Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?
D Gaist, L A García Rodríguez, C Huerta, et al.
European Journal of Neurology
|
July 22, 2014
Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy
L H Markvardsen, T Harbo, S H Sindrup, et al.
Pain
|
October 11, 2005
Algorithm for neuropathic pain treatment: an evidence based proposal
N B Finnerup, M Otto, H J McQuay, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 76) with videos related to
Sort By:
Page
of 8
European Journal of Neurology
|
July 27, 2004
Therapeutic outcome in neuropathic pain: relationship to evidence of nervous system lesion
P V Rasmussen, S H Sindrup, T S Jensen, et al.
Psychopharmacology Series
|
January 1, 1993
Role of genetic polymorphism in psychopharmacology--an update
K Brøsen, S H Sindrup, E Skjelbo, et al.
Acta Anaesthesiologica Scandinavica
|
September 2, 2009
Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia
S T Zwisler, T P Enggaard, S Mikkelsen, et al.
European Journal of Neurology
|
February 25, 2009
Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial
T Harbo, H Andersen, A Hess, et al.
European Journal of Neurology
|
April 26, 2019
Randomized trial of facilitated subcutaneous immunoglobulin in multifocal motor neuropathy
A Al-Zuhairy, J Jakobsen, H Andersen, et al.
Clinical Pharmacology and Therapeutics
|
May 21, 2005
Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective O-demethylation and reduces the hypoalgesic effect of tramadol
S Laugesen, T P Enggaard, R S Pedersen, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1990
Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms
S H Sindrup, L F Gram, T Skjold, et al.
European Journal of Clinical Pharmacology
|
April 25, 2001
Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?
D Gaist, L A García Rodríguez, C Huerta, et al.
European Journal of Neurology
|
July 22, 2014
Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy
L H Markvardsen, T Harbo, S H Sindrup, et al.
Pain
|
October 11, 2005
Algorithm for neuropathic pain treatment: an evidence based proposal
N B Finnerup, M Otto, H J McQuay, et al.
Page
of 8